XML 40 R30.htm IDEA: XBRL DOCUMENT v3.22.2
STOCK BASED COMPENSATION (Tables)
6 Months Ended
Jun. 30, 2022
Stock-based compensation  
Schedule of stock-based compensation expenses

Three Months Ended

Six Months Ended

June 30, 

June 30, 

(in thousands)

    

2022

    

2021

    

2022

    

2021

Research and development

$

788

$

533

$

1,644

$

1,332

General and administrative

 

1,443

 

2,169

 

2,664

 

4,351

Total stock-based compensation expense

$

2,231

$

2,702

$

4,308

$

5,683

Schedule of options outstanding

    

    

    

Weighted-Average

    

 

 

Weighted-

 

Remaining

 

Aggregate

Options

 

Average

 

Contractual

 

Intrinsic

(in thousands, except for share data)

Outstanding

Exercise Price

 

Term (in years)

Value

Outstanding at December 31, 2021

 

4,704,888

$

13.29

7.7

$

10,305

Options granted

 

767,913

2.80

Options exercised

 

-

Forfeited

 

(271,095)

26.64

Expired

 

(132,269)

32.85

Outstanding at June 30, 2022

 

5,069,437

$

10.47

7.4

$

Exercisable at June 30, 2022

 

3,613,024

$

9.35

7.0

$

Nonvested at June 30, 2022

 

1,456,413

$

13.26

8.7

$

Schedule of restricted stock units outstanding

 

 

Weighted-Average

 

 

Grant Date

 

Aggregate

(in thousands, except for share data)

Shares

 

Fair Value

Intrinsic Value

Outstanding at December 31, 2021

 

469,485

$

18.05

$

4,202

Awarded

 

305,600

3.78

Released

 

(38,010)

26.07

Forfeited

 

(160,506)

19.08

Outstanding at June 30, 2022

 

576,569

$

9.67

$

547

Nonvested at June 30, 2022

 

576,569

$

9.67

$

547

Weighted Average Remaining Recognition Period (in years)

3.3

Stock options - Service conditions only  
Stock-based compensation  
Schedule of valuation assumptions

Six Months Ended

 

June 30, 

    

2022

 

2021

Expected term (in years)

5.7

5.4

Volatility

 

75.83

%

69.85

%

Risk-free interest rate

 

2.13

%

0.91

%

Dividend yield

%

%